JP7579817B2 - Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化 - Google Patents

Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化 Download PDF

Info

Publication number
JP7579817B2
JP7579817B2 JP2021577412A JP2021577412A JP7579817B2 JP 7579817 B2 JP7579817 B2 JP 7579817B2 JP 2021577412 A JP2021577412 A JP 2021577412A JP 2021577412 A JP2021577412 A JP 2021577412A JP 7579817 B2 JP7579817 B2 JP 7579817B2
Authority
JP
Japan
Prior art keywords
sequences
target
specific
outputting
target site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021577412A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540792A5 (cg-RX-API-DMAC10.html
JP2022540792A (ja
Inventor
リー，ヘン
クルガン，ギャビン
マクニール，マシュー
ワン，ユー
Original Assignee
インテグレーティッド ディーエヌエイ テクノロジーズ インコーポレーティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インテグレーティッド ディーエヌエイ テクノロジーズ インコーポレーティッド filed Critical インテグレーティッド ディーエヌエイ テクノロジーズ インコーポレーティッド
Publication of JP2022540792A publication Critical patent/JP2022540792A/ja
Publication of JP2022540792A5 publication Critical patent/JP2022540792A5/ja
Priority to JP2024188978A priority Critical patent/JP7898488B2/ja
Application granted granted Critical
Publication of JP7579817B2 publication Critical patent/JP7579817B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20—Sequence assembly
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021577412A 2019-07-03 2020-07-02 Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化 Active JP7579817B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024188978A JP7898488B2 (ja) 2019-07-03 2024-10-28 Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962870471P 2019-07-03 2019-07-03
US201962870426P 2019-07-03 2019-07-03
US62/870,471 2019-07-03
US62/870,426 2019-07-03
US201962952598P 2019-12-23 2019-12-23
US201962952603P 2019-12-23 2019-12-23
US62/952,603 2019-12-23
US62/952,598 2019-12-23
PCT/US2020/040621 WO2021003343A1 (en) 2019-07-03 2020-07-02 Identification, characterization, and quantitation of crispr-introduced double-stranded dna break repairs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024188978A Division JP7898488B2 (ja) 2019-07-03 2024-10-28 Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化

Publications (3)

Publication Number Publication Date
JP2022540792A JP2022540792A (ja) 2022-09-20
JP2022540792A5 JP2022540792A5 (cg-RX-API-DMAC10.html) 2023-04-18
JP7579817B2 true JP7579817B2 (ja) 2024-11-08

Family

ID=74065411

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577412A Active JP7579817B2 (ja) 2019-07-03 2020-07-02 Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化
JP2024188978A Active JP7898488B2 (ja) 2019-07-03 2024-10-28 Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024188978A Active JP7898488B2 (ja) 2019-07-03 2024-10-28 Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化

Country Status (7)

Country Link
US (2) US12254959B2 (cg-RX-API-DMAC10.html)
EP (1) EP3994258A4 (cg-RX-API-DMAC10.html)
JP (2) JP7579817B2 (cg-RX-API-DMAC10.html)
AU (1) AU2020301025B2 (cg-RX-API-DMAC10.html)
CA (1) CA3144106A1 (cg-RX-API-DMAC10.html)
IL (1) IL289421A (cg-RX-API-DMAC10.html)
WO (1) WO2021003343A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3154370A1 (en) 2019-10-24 2021-04-29 Jessica WOODLEY Modified double-stranded donor templates
CN119343462A (zh) 2022-05-13 2025-01-21 合成Dna技术公司 使用独特分子标识符改善长读测序的准确性和crispr编辑的表征
US20260049352A1 (en) 2024-08-14 2026-02-19 Integrated Dna Technologies, Inc. Adaptered-tag blocking oligonucleotides

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170053062A1 (en) 2014-01-27 2017-02-23 Georgia Tech Research Corporation Methods and systems for identifying crispr/cas off-target sites
US20170211142A1 (en) 2015-10-22 2017-07-27 The Broad Institute, Inc. Novel crispr enzymes and systems
US20180068062A1 (en) 2016-08-17 2018-03-08 The Broad Institute, Inc. Methods for identifying novel gene editing elements
US20180163265A1 (en) 2014-12-19 2018-06-14 The Broad Institute Inc. Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing
JP2018518183A (ja) 2015-06-18 2018-07-12 ザ・ブロード・インスティテュート・インコーポレイテッド 新規ｃｒｉｓｐｒ酵素及び系
JP2019504646A (ja) 2016-02-11 2019-02-21 ホライズン・ディスカバリー・リミテッド 複製的トランスポゾン系

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9809904B2 (en) 2011-04-21 2017-11-07 University Of Washington Through Its Center For Commercialization Methods for retrieval of sequence-verified DNA constructs
CN105531375B (zh) 2012-12-10 2020-03-03 分析生物科学有限公司 靶向基因组分析的方法
AU2013381709A1 (en) 2013-03-15 2015-10-01 Integrated Dna Technologies, Inc. RNase H-based assays utilizing modified RNA monomers
US11306328B2 (en) 2013-07-26 2022-04-19 President And Fellows Of Harvard College Genome engineering
AU2015280069B2 (en) 2014-06-23 2021-08-12 The General Hospital Corporation Genomewide unbiased identification of dsbs evaluated by sequencing (guide-seq)
WO2016030899A1 (en) 2014-08-28 2016-03-03 Yeda Research And Development Co. Ltd. Methods of treating amyotrophic lateral scleroses
WO2016081798A1 (en) 2014-11-20 2016-05-26 Children's Medical Center Corporation Methods relating to the detection of recurrent and non-specific double strand breaks in the genome
EP3262189B1 (en) 2015-02-27 2021-12-08 Becton, Dickinson and Company Methods for barcoding nucleic acids for sequencing
CA2989445A1 (en) 2015-06-22 2016-12-29 Mcmaster University Biosensor comprising tandem reactions of structure switching, nucleolytic digestion and amplification of a nucleic acid assembly
US10526590B2 (en) 2015-08-31 2020-01-07 Agilent Technologies, Inc. Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination
US20170081679A1 (en) 2015-09-22 2017-03-23 Jie Xu Methods of improving nuclease mediated homologous recombination
JP7011590B2 (ja) 2015-10-12 2022-02-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 細胞内での遺伝子組換えおよび相同組換えの増加のための保護ｄｎａ鋳型および使用方法
US20170145486A1 (en) 2015-11-25 2017-05-25 Integrated Dna Technologies, Inc. Methods for variant detection
CN118460529A (zh) 2016-12-20 2024-08-09 百时美施贵宝公司 提高细胞基因组中同源定向修复(hdr)效率的方法
CN111032867A (zh) 2017-06-16 2020-04-17 应用干细胞有限公司 具有提高的敲入效率的基因编辑方法
US20190062736A1 (en) * 2017-08-22 2019-02-28 Board Of Regents, The University Of Texas System In situ and in vivo analysis of chromatin interactions by biotinylated dcas9 protein
CN111315889A (zh) 2017-09-08 2020-06-19 生命技术公司 提高同源重组的方法和其组合物
WO2019110067A1 (en) 2017-12-07 2019-06-13 Aarhus Universitet Hybrid nanoparticle
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
EP3770256A4 (en) 2018-03-20 2021-12-22 Tokyo Institute of Technology ANTISENSE OLIGONUCLEOTIDE WITH REDUCED TOXICITY
WO2019246553A1 (en) * 2018-06-21 2019-12-26 Memorial Sloan Kettering Cancer Center Compositions & methods for monitoring dna repair
WO2020178772A1 (en) 2019-03-04 2020-09-10 King Abdullah University Of Science And Technology Compositions and methods of labeling nucleic acids and sequencing and analysis thereof
CA3154370A1 (en) 2019-10-24 2021-04-29 Jessica WOODLEY Modified double-stranded donor templates

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170053062A1 (en) 2014-01-27 2017-02-23 Georgia Tech Research Corporation Methods and systems for identifying crispr/cas off-target sites
US20180163265A1 (en) 2014-12-19 2018-06-14 The Broad Institute Inc. Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing
JP2018518183A (ja) 2015-06-18 2018-07-12 ザ・ブロード・インスティテュート・インコーポレイテッド 新規ｃｒｉｓｐｒ酵素及び系
US20170211142A1 (en) 2015-10-22 2017-07-27 The Broad Institute, Inc. Novel crispr enzymes and systems
JP2019504646A (ja) 2016-02-11 2019-02-21 ホライズン・ディスカバリー・リミテッド 複製的トランスポゾン系
US20180068062A1 (en) 2016-08-17 2018-03-08 The Broad Institute, Inc. Methods for identifying novel gene editing elements

Also Published As

Publication number Publication date
AU2020301025A1 (en) 2022-01-20
US12254959B2 (en) 2025-03-18
CA3144106A1 (en) 2021-01-07
AU2020301025B2 (en) 2026-07-02
JP7898488B2 (ja) 2026-07-31
JP2025014002A (ja) 2025-01-28
JP2022540792A (ja) 2022-09-20
US20210002700A1 (en) 2021-01-07
EP3994258A1 (en) 2022-05-11
IL289421A (en) 2022-02-01
EP3994258A4 (en) 2022-10-26
WO2021003343A1 (en) 2021-01-07
US20250218536A1 (en) 2025-07-03

Similar Documents

Publication Publication Date Title
Höijer et al. CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
JP2025014002A (ja) Ｃｒｉｓｐｒで導入された二本鎖ｄｎａ切断修復の同定、特徴付けおよび定量化
US12146195B2 (en) Methods for lung cancer detection
Fu et al. Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity
EP3699292B1 (en) High-throughput genotyping by sequencing low amounts of genetic material
US12106825B2 (en) Computational modeling of loss of function based on allelic frequency
KR20210059694A (ko) 게놈 편집, 클론 팽창 및 연관된 분야를 규명하기 위한 방법 및 시약
US10513726B2 (en) Methods for controlled identification and/or quantification of transcript variants in one or more samples
US20180355380A1 (en) Methods and kits for quality control
CN110607356B (zh) 一种基因组编辑检测方法、试剂盒及应用
Peterson et al. Whole genome analysis for 163 gRNAs in Cas9-edited mice reveals minimal off-target activity
JP2024113001A (ja) デザイナヌクレアーゼを用いる修飾の特徴付け方法
JP7724785B2 (ja) 複雑なゲノム領域を解析するための方法およびシステム
Lamb et al. Complex mutation profiles in mismatch repair and ribonucleotide reductase mutants reveal novel repair substrate specificity of MutS homolog (MSH) complexes
US20230366020A1 (en) Use of unique molecular identifiers for improved accuracy of long read sequencing and characterization of crispr editing
US20240209442A1 (en) Methods and systems for analyzing complex genomic regions
Keraite et al. Novel method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome
Uppuluri et al. A long-read sequencing strategy with overlapping linkers on adjacent fragments (OLAF-Seq) for targeted resequencing and enrichment
Varapula et al. Recent Applications of CRISPR-Cas9 in Genome Mapping and Sequencing
Uppuluri et al. Linked-Pair Long-Read Sequencing Strategy for Targeted Resequencing and Enrichment
US9637779B2 (en) Antisense transcriptomes of cells
HK40004815A (en) Method and device for acquiring fetal free dna concentration
HK40004815B (en) Method and device for acquiring fetal free dna concentration

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240828

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240930

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241028

R150 Certificate of patent or registration of utility model

Ref document number: 7579817

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150